CMG PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 058820 for the last quarter is 21.98 B KRW, and it's 6.61% lower compared to the previous quarter. The net income of Q4 23 is -2.65 B KRW.